Topic: Vivus Inc.
Welcome to TheStreet's 2012 FDA Drug Approval Prediction Contest. Your challenge: Correctly pick the approval decisions to be made by the U.S. Food...
Investment analysts at MLV Co increased their price target on shares of VIVUS (NASDAQ: VVUS) from $16.00 to $22.00 in a note issued to investors...
The 2012 J.P. Morgan Healthcare Conference is in the books. Here's what I learned: It was good week for biotech stocks, with the Nasdaq...
VIVUS, Inc. today announced that following recent discussions with Food and Drug Administration (FDA) officials, the company has been asked to...
3,641,254 shares of VIVUS, Inc. (VVUS) traded hands on Monday, a 92.41% increase in volume compared to its 20-day average. The stock last traded at...
Biotech Stock Live Chat Welcome to December's Biotech Stock Mailbag Live Chat. The floor is yours. I'm here for the next 90 minutes to answer your...
Equities research analysts at Bank of America (NYSE: BAC) raised their price target on shares of VIVUS (NASDAQ: VVUS) to $14.00 in a research...
VIVUS (NASDAQ: VVUS)'s stock had its "underperform" rating reaffirmed by equities research analysts at Jefferies in a research note issued to...
If at first you don't succeed, keep trying until the money runs out. That would seem to be the underlying strategy at Vivus (Nasdaq:VVUS), as this...
Posted on 10/21/11 at 10:45am by Matthew Kennedy . Earlier this week, Vivus announced that it had resubmitted an NDA for its weight loss drug...
Video Gallery
-
Vivus Down 57% Following US Food ...
Shares of Vivus, Inc. (NASDAQ:VVUS) experienced a staggering 57 ...2010-07-16 -
VIVUS Applies for Market Authorization of ...
VIVUS, Inc. (NASDAQ:VVUS) applied for authorization to market its ...2010-12-20 -
IDIX, BVSN, MDVN, JAZZ - Stock Charts ...
1/09/12 - It was a mixed day on Wall ...2012-01-10
